Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;50:276-283
Published online before print June 4, 2007, doi: 10.1161/HYPERTENSIONAHA.107.089854
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
50/2/276    most recent
HYPERTENSIONAHA.107.089854v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gleissner, C. A.
Right arrow Articles by Ley, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gleissner, C. A.
Right arrow Articles by Ley, K.
Related Collections
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Chronic ischemic heart disease
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors

(Hypertension. 2007;50:276.)
© 2007 American Heart Association, Inc.


Brief Reviews

Effects of Native and Modified Low-Density Lipoproteins on Monocyte Recruitment in Atherosclerosis

Christian A. Gleissner; Norbert Leitinger; Klaus Ley

From the Departments of Biomedical Engineering (C.A.G., K.L.), Pharmacology (N.L.), Molecular Physiology and Biological Physics (K.L.), and the Robert M. Berne Cardiovascular Research Center (C.A.G., N.L., K.L.), University of Virginia, Charlottesville.

Correspondence to Klaus Ley, MD, Robert M. Berne Cardiovascular Research Center, University of Virginia, P.O. Box 801394, Charlottesville, VA 22908. E-mail klausley@virginia.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Atherosclerosis is a chronic inflammatory disease of the arterial wall1–3 with enormous epidemiological relevance.4,5 Recruitment of monocytes to the vascular wall is a key feature in the pathogeneses of atherosclerotic lesions. Through a complex cascade of interactions between adhesion molecules and chemotactic factors, monocytes enter the subendothelial space, where they develop into macrophages, foam cells, and dendritic cells under the influence of cytokines, growth factors, and lipoproteins.6–8 Foam cells eventually undergo secondary necrosis and form the lipid core of advanced atherosclerotic plaques. When exposed by rupture or erosion, it triggers acute thrombotic events leading to myocardial infarction and strokes.9

Elevated serum levels of low-density lipoprotein (LDL) (see the Table for abbreviations) are a major risk factor for the development of atherosclerosis.4 Apart from epidemiological evidence for the proatherogenic role of lipoproteins, mechanistic studies suggest that they play a role in monocyte recruitment to the vessel wall and the progression of macrophages to foam cells. LDL does not only occur in its native form, but modified forms of LDL—eg, by oxidation, aggregation, or other processes—are thought to be even more proatherogenic.10–13


View this table:



 
Abbreviations Used in the Text

Even though numerous reviews have focused on monocyte recruitment to the arterial wall14–16 or on effects of LDL on foam cell formation7,14 in atherogenesis, no recent review has specifically addressed the effects of native and modified LDL on monocyte recruitment to the vessel wall. Here, we discuss the molecular effects of LDL on monocyte recruitment to the arterial wall as a crucial step in the . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
T. Chen, Z. Huang, L. Wang, Y. Wang, F. Wu, S. Meng, and C. Wang
MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages
Cardiovasc Res, July 1, 2009; 83(1): 131 - 139.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Kisucka, A. K. Chauhan, I. S. Patten, A. Yesilaltay, C. Neumann, R. A. Van Etten, M. Krieger, and D. D. Wagner
Peroxiredoxin1 Prevents Excessive Endothelial Activation and Early Atherosclerosis
Circ. Res., September 12, 2008; 103(6): 598 - 605.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Galkina and K. Ley
Vascular Adhesion Molecules in Atherosclerosis
Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2292 - 2301.
[Abstract] [Full Text] [PDF]